Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

More articles from ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

  • You have access
    Human CYP1B1 and Anticancer Agent Metabolism: Mechanism for Tumor-Specific Drug Inactivation?
    Bertrand Rochat, Janine M. Morsman, Graeme I. Murray, William D. Figg and Howard L. McLeod
    Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 537-541;
  • You have access
    Characterization of a Novel Cationic Drug Transporter in Human Retinal Pigment Epithelial Cells
    Yong-Hae Han, Douglas H. Sweet, Dan-Ning Hu and John B. Pritchard
    Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 450-457;
  • You have access
    Pharmacokinetics and Pharmacodynamics of an Antisense Phosphorothioate Oligonucleotide Targeting Fas mRNA in Mice
    Rosie Z. Yu, Hong Zhang, Richard S. Geary, Mark Graham, Lilit Masarjian, Kristina Lemonidis, Rosanne Crooke, Nicholas M. Dean and Arthur A. Levin
    Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 388-395;
  • You have access
    Modulation of P450 CYP3A4-Dependent Metabolism by P-glycoprotein: Implications for P450 Phenotyping
    Jens M. Baron, Lay Beng Goh, Denggao Yao, C. Roland Wolf and Thomas Friedberg
    Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 351-358;
  • You have access
    Synthesis of 5-Oxo-6,8,11,14-eicosatetraenoic Acid and Identification of Novel ω-Oxidized Metabolites in the Mouse Macrophage
    John M. Hevko, Rebecca C. Bowers and Robert C. Murphy
    Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 293-305;
  • You have access
    Probenecid-Associated Alterations in Valproate Glucuronide Hepatobiliary Disposition: Mechanistic Assessment Using Mathematical Modeling
    E. Stacy Ward, Gary M. Pollack and Kim L. R. Brouwer
    Journal of Pharmacology and Experimental Therapeutics April 2001, 297 (1) 141-147;
  • You have access
    Regulation of Hepatic Cytochrome P450 2C11 via cAMP: Implications for Down-Regulation in Diabetes, Fasting, and Inflammation
    Heinrich Iber, Tong Li-Masters, Qi Chen, Sheng Yu and Edward T. Morgan
    Journal of Pharmacology and Experimental Therapeutics April 2001, 297 (1) 174-180;
  • You have access
    Transcriptional and Post-Translational Regulation of CYP1A1 by Primaquine
    Veronica Werlinder, Maria Backlund, Andrei Zhukov and Magnus Ingelman-Sundberg
    Journal of Pharmacology and Experimental Therapeutics April 2001, 297 (1) 206-214;
  • You have access
    Application of the Relative Activity Factor Approach in Scaling from Heterologously Expressed Cytochromes P450 to Human Liver Microsomes: Studies on Amitriptyline as a Model Substrate
    Karthik Venkatakrishnan, Lisa L. von Moltke and David J. Greenblatt
    Journal of Pharmacology and Experimental Therapeutics April 2001, 297 (1) 326-337;
  • You have access
    Metabolism of levo-α-Acetylmethadol (LAAM) by Human Liver Cytochrome P450: Involvement of CYP3A4 Characterized by Atypical Kinetics with Two Binding Sites
    Yutaka Oda and Evan D. Kharasch
    Journal of Pharmacology and Experimental Therapeutics April 2001, 297 (1) 410-422;

Pages

  • Previous
  • Next
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 49
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics